dr holst glp 1 Exclusive interview: Jens Juul Dr. Jens Juul Holst: GLP-1

While the regulator has not approved their use in type 1 diabetes, off-label prescribing for GLP-1 receptor agonists has sharply increased, according to researchers, who warn about the risk of serious side effects such as ketoacidosis.

Learn what retatrutide does and how it affects appetite, blood sugar and energy use

Indias GLP1 Generic Surge: Pen Makers Set to Win Big The weight-loss drug market is reaching a tipping point and India's pharma supply chain is poised for a major breakthrough

The results prompt safety concerns for GLP-1RAs, especially with high dose administration, regarding gastrointestinal adverse events

Insurance isnt likely to cover Ozempic for prediabetes, but it may cover Ozempic with prior authorization or step therapy along with lifestyle changes.